$LFT
Lument Finance Trust, Inc.

2022 Q1 Form 10-Q Financial Statement

#000162828022013368 Filed on May 09, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $10.01M $7.470M
YoY Change 34.06% -18.75%
Cost Of Revenue $4.927M $2.960M
YoY Change 66.45% -41.04%
Gross Profit $5.087M $4.520M
YoY Change 12.55% 8.13%
Gross Profit Margin 50.8% 60.51%
Selling, General & Admin $2.219M $1.760M
YoY Change 26.08% -5.88%
% of Gross Profit 43.62% 38.94%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $2.295M $1.790M
YoY Change 28.22% -17.4%
Operating Profit $2.792M $2.730M
YoY Change 2.27% 35.62%
Interest Expense $150.0K -$20.00K
YoY Change -850.0% -100.4%
% of Operating Profit 5.37% -0.73%
Other Income/Expense, Net
YoY Change
Pretax Income $3.006M $2.820M
YoY Change 6.61% 112.03%
Income Tax $51.67K $14.71K
% Of Pretax Income 1.72% 0.52%
Net Earnings $2.955M $2.809M
YoY Change 5.2% 81.01%
Net Earnings / Revenue 29.51% 37.6%
Basic Earnings Per Share $0.05 $0.11
Diluted Earnings Per Share $0.05 $0.11
COMMON SHARES
Basic Shares Outstanding 36.46M shares 24.94M shares
Diluted Shares Outstanding 36.46M shares 24.94M shares

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $45.85M $11.70M
YoY Change 291.85% 3.54%
Cash & Equivalents $45.85M $11.72M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $48.57M $48.40M
YoY Change 0.34% 253.28%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.343M $32.20M
YoY Change -95.83% 366.67%
Total Long-Term Assets $1.081B $519.0M
YoY Change 108.34% -20.19%
TOTAL ASSETS
Total Short-Term Assets $48.57M $48.40M
Total Long-Term Assets $1.081B $519.0M
Total Assets $1.130B $567.4M
YoY Change 99.13% -14.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $312.0K $300.0K
YoY Change 4.0% -57.14%
Accrued Expenses $817.1K $400.0K
YoY Change 104.26% -33.33%
Deferred Revenue
YoY Change
Short-Term Debt $827.4M $409.4M
YoY Change 102.1% -19.15%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $834.0M $413.6M
YoY Change 101.64% -19.0%
LONG-TERM LIABILITIES
Long-Term Debt $46.78M $39.60M
YoY Change 18.14% 0.51%
Other Long-Term Liabilities $300.0K $300.0K
YoY Change 0.0% -57.14%
Total Long-Term Liabilities $46.78M $39.60M
YoY Change 18.14% 0.51%
TOTAL LIABILITIES
Total Short-Term Liabilities $834.0M $413.6M
Total Long-Term Liabilities $46.78M $39.60M
Total Liabilities $880.8M $453.1M
YoY Change 94.37% -17.6%
SHAREHOLDERS EQUITY
Retained Earnings $24.34M $13.67M
YoY Change 78.09% 245.0%
Common Stock $522.2K $249.4K
YoY Change 109.39% 0.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $249.0M $114.2M
YoY Change
Total Liabilities & Shareholders Equity $1.130B $567.4M
YoY Change 99.13% -14.55%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $2.955M $2.809M
YoY Change 5.2% 81.01%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $4.556M $3.172M
YoY Change 43.62% 33.74%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$53.24M $28.64M
YoY Change -285.88% -796.84%
Cash From Investing Activities -$53.24M $28.64M
YoY Change -285.87% -797.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $81.14M $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $77.59M -$57.32M
YoY Change -235.37% -1543.57%
NET CHANGE
Cash From Operating Activities $4.556M $3.172M
Cash From Investing Activities -$53.24M $28.64M
Cash From Financing Activities $77.59M -$57.32M
Net Change In Cash $28.91M -$25.50M
YoY Change -213.36% -1240.28%
FREE CASH FLOW
Cash From Operating Activities $4.556M $3.172M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001547546
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-35845
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
LUMENT FINANCE TRUST, INC.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-4966519
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
230 Park Avenue
CY2022Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
20th Floor
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10169
CY2022Q1 dei City Area Code
CityAreaCode
212
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
317-5700
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
52225152 shares
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45846521 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14749046 USD
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1342733 USD
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3530006 USD
CY2022Q1 us-gaap Notes Receivable Net
NotesReceivableNet
1077516319 USD
CY2021Q4 us-gaap Notes Receivable Net
NotesReceivableNet
1001825294 USD
CY2022Q1 oaks Mortgage Service Rights At Fair Value
MortgageServiceRightsAtFairValue
699379 USD
CY2021Q4 oaks Mortgage Service Rights At Fair Value
MortgageServiceRightsAtFairValue
551997 USD
CY2022Q1 us-gaap Interest Receivable
InterestReceivable
2718488 USD
CY2021Q4 us-gaap Interest Receivable
InterestReceivable
3977752 USD
CY2022Q1 oaks Paydown Receivable
PaydownReceivable
0 USD
CY2021Q4 oaks Paydown Receivable
PaydownReceivable
22400000 USD
CY2022Q1 us-gaap Other Assets
OtherAssets
1734336 USD
CY2021Q4 us-gaap Other Assets
OtherAssets
1889258 USD
CY2022Q1 us-gaap Assets
Assets
1129857776 USD
CY2021Q4 us-gaap Assets
Assets
1048923353 USD
CY2022Q1 oaks Collateralized Loan Obligations
CollateralizedLoanObligations
827405880 USD
CY2021Q4 oaks Collateralized Loan Obligations
CollateralizedLoanObligations
826782543 USD
CY2022Q1 us-gaap Secured Long Term Debt
SecuredLongTermDebt
46783300 USD
CY2021Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
46845502 USD
CY2022Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
817051 USD
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
704055 USD
CY2022Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
4134717 USD
CY2021Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
3242809 USD
CY2022Q1 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
1324000 USD
CY2021Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
1825142 USD
CY2022Q1 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
311985 USD
CY2021Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
147802 USD
CY2022Q1 us-gaap Liabilities
Liabilities
880776933 USD
CY2021Q4 us-gaap Liabilities
Liabilities
879547853 USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q1 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.07875
CY2021 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.07875
CY2021Q4 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
60000000 USD
CY2022Q1 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
60000000 USD
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2400000 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2400000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2400000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2400000 shares
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
57254935 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
57254935 USD
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
52225152 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52225152 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24947883 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24947883 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
522207 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
249434 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
314629987 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
233833749 USD
CY2022Q1 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
147767777 USD
CY2021Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
143449310 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
24341991 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
21387192 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
248981343 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
169276000 USD
CY2022Q1 us-gaap Minority Interest
MinorityInterest
99500 USD
CY2021Q4 us-gaap Minority Interest
MinorityInterest
99500 USD
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
249080843 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
169375500 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1129857776 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1048923353 USD
CY2022Q1 us-gaap Interest And Fee Income Loans Commercial Real Estate
InterestAndFeeIncomeLoansCommercialRealEstate
10009064 USD
CY2021Q1 us-gaap Interest And Fee Income Loans Commercial Real Estate
InterestAndFeeIncomeLoansCommercialRealEstate
7470117 USD
CY2022Q1 us-gaap Interest Income And Fees Bankers Acceptances Certificates Of Deposit And Commercial Paper
InterestIncomeAndFeesBankersAcceptancesCertificatesOfDepositAndCommercialPaper
4855 USD
CY2021Q1 us-gaap Interest Income And Fees Bankers Acceptances Certificates Of Deposit And Commercial Paper
InterestIncomeAndFeesBankersAcceptancesCertificatesOfDepositAndCommercialPaper
4300 USD
CY2022Q1 oaks Interest Expense Collateralized Loan Obligations
InterestExpenseCollateralizedLoanObligations
4004238 USD
CY2021Q1 oaks Interest Expense Collateralized Loan Obligations
InterestExpenseCollateralizedLoanObligations
2185242 USD
CY2022Q1 oaks Interest Expense Secured Term Loan
InterestExpenseSecuredTermLoan
922643 USD
CY2021Q1 oaks Interest Expense Secured Term Loan
InterestExpenseSecuredTermLoan
771865 USD
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
5087038 USD
CY2021Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
4517310 USD
CY2022Q1 oaks Unrealized Gain Loss On Mortgage Service Rights
UnrealizedGainLossOnMortgageServiceRights
147382 USD
CY2021Q1 oaks Unrealized Gain Loss On Mortgage Service Rights
UnrealizedGainLossOnMortgageServiceRights
-20455 USD
CY2022Q1 us-gaap Fees And Commissions Mortgage Banking And Servicing
FeesAndCommissionsMortgageBankingAndServicing
67181 USD
CY2021Q1 us-gaap Fees And Commissions Mortgage Banking And Servicing
FeesAndCommissionsMortgageBankingAndServicing
124156 USD
CY2022Q1 oaks Other Noninterest Income Loss
OtherNoninterestIncomeLoss
214563 USD
CY2021Q1 oaks Other Noninterest Income Loss
OtherNoninterestIncomeLoss
103701 USD
CY2022Q1 oaks Management And Incentive Fees
ManagementAndIncentiveFees
924617 USD
CY2021Q1 oaks Management And Incentive Fees
ManagementAndIncentiveFees
720999 USD
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
852732 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
680314 USD
CY2022Q1 oaks Reimbursable Operating Expense
ReimbursableOperatingExpense
390710 USD
CY2021Q1 oaks Reimbursable Operating Expense
ReimbursableOperatingExpense
312454 USD
CY2022Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-76190 USD
CY2021Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-34753 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
50888 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
49135 USD
CY2022Q1 us-gaap Noninterest Expense
NoninterestExpense
2295137 USD
CY2021Q1 us-gaap Noninterest Expense
NoninterestExpense
1797655 USD
CY2022Q1 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
3006464 USD
CY2021Q1 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
2823356 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
51665 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14713 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
2954799 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
2808643 USD
CY2022Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
1184958 USD
CY2021Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
3708 USD
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1769841 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2804935 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
2954799 USD
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1769841 USD
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1769841 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
2804935 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2804935 USD
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36464952 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24943383 shares
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.06
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.09
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
169375500 USD
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
83468443 USD
CY2022Q1 oaks Cost Of Issuing Of Common Stock Values
CostOfIssuingOfCommonStockValues
2404070 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
4638 USD
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
3133509 USD
CY2022Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1184958 USD
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
249080843 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
113703152 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
2885 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
2808643 USD
CY2021Q1 us-gaap Dividends Common Stock
DividendsCommonStock
2244904 USD
CY2021Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
3708 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
114266068 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
2954799 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
2808643 USD
CY2022Q1 oaks Accretion Of Discounts On Held For Investment Loans
AccretionOfDiscountsOnHeldForInvestmentLoans
100572 USD
CY2021Q1 oaks Accretion Of Discounts On Held For Investment Loans
AccretionOfDiscountsOnHeldForInvestmentLoans
-207767 USD
CY2022Q1 oaks Amortization Of Premiums On Held For Investment Loans
AmortizationOfPremiumsOnHeldForInvestmentLoans
45349 USD
CY2021Q1 oaks Amortization Of Premiums On Held For Investment Loans
AmortizationOfPremiumsOnHeldForInvestmentLoans
0 USD
CY2022Q1 oaks Amortization Of Offering Costs
AmortizationOfOfferingCosts
-71671 USD
CY2021Q1 oaks Amortization Of Offering Costs
AmortizationOfOfferingCosts
0 USD
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
680510 USD
CY2021Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
253254 USD
CY2022Q1 oaks Unrealized Gain Loss On Mortgage Service Rights
UnrealizedGainLossOnMortgageServiceRights
147382 USD
CY2021Q1 oaks Unrealized Gain Loss On Mortgage Service Rights
UnrealizedGainLossOnMortgageServiceRights
-20455 USD
CY2022Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
4638 USD
CY2021Q1 us-gaap Restricted Stock Expense
RestrictedStockExpense
2885 USD
CY2022Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-1259264 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
157390 USD
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-154922 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-75880 USD
CY2022Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
112996 USD
CY2021Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-39806 USD
CY2022Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-501142 USD
CY2021Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
48348 USD
CY2022Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
164183 USD
CY2021Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-47753 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4555894 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3172283 USD
CY2022Q1 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
184992167 USD
CY2021Q1 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
34888000 USD
CY2022Q1 us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
131756365 USD
CY2021Q1 us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
98068085 USD
CY2022Q1 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
0 USD
CY2021Q1 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
34539187 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-53235802 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
28640898 USD
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
81136044 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2022Q1 oaks Payment Of Collateralized Loan Obligations
PaymentOfCollateralizedLoanObligations
0 USD
CY2021Q1 oaks Payment Of Collateralized Loan Obligations
PaymentOfCollateralizedLoanObligations
54073905 USD
CY2022Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
119375 USD
CY2021Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2245309 USD
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3242640 USD
CY2022Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
1181250 USD
CY2021Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
0 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
77590110 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-57316545 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
28910202 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-25503364 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18279052 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
69375356 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47189254 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
43871992 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
4133373 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
2535893 USD
CY2022Q1 oaks Dividends Declared Not Yet Paid
DividendsDeclaredNotYetPaid
4318467 USD
CY2021Q1 oaks Dividends Declared Not Yet Paid
DividendsDeclaredNotYetPaid
2248612 USD
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The financial statements have been prepared on the accrual basis of accounting in accordance with GAAP. The preparation of financial statements in conformity with GAAP requires the Company to make a number of significant estimates. As of March 31, 2022, the novel coronavirus, or COVID-19, pandemic is ongoing. During 2020, the COVID-19 pandemic created disruption in global supply chains, increased rates of unemployment and adversely impacted many industries, including industries related to the collateral underlying certain of our loans. In 2021, the global economy, with certain setbacks, began reopening and wider distribution of vaccines encouraged greater economic activity. Nonetheless, the recovery could remain uneven, particularly given uncertainty with respect to the distribution and acceptance of the vaccines and their effectiveness with respect to new variants of the virus, which are believed to be more contagious than previous variants of the virus. We believe the estimates and assumptions underlying our consolidated financial statements are reasonable and supportable based on the information available as of March 31, 2022, however uncertainty over the ultimate impact of COVID-19 on the global economy generally, and our business in particular, makes any estimates and assumptions as of March 31, 2022 inherently less certain than they would be absent the current and potential impacts of COVID-19. Actual results could differ from our estimates and the differences may be material.</span></div>
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45846521 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14749046 USD
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1342733 USD
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3530006 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47189254 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18279052 USD
CY2022Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
0 USD
CY2022Q1 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
0 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
0 USD
CY2022Q1 oaks Number Of Sub Servers
NumberOfSubServers
2 sub-servicer
CY2022Q1 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
1524508 USD
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52225152 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
52225152 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
52225152 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52225152 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24947883 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24947883 shares
CY2015Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
10000000 USD
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2400000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2400000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2400000 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2400000 shares
CY2022Q1 oaks One Month Libor Rate
OneMonthLIBORRate
0.0029 USD
CY2021Q4 oaks One Month Libor Rate
OneMonthLIBORRate
0.0010 USD
CY2022Q1 oaks One Month Sofr Rate
OneMonthSOFRRate
0.0024
CY2021Q4 oaks One Month Sofr Rate
OneMonthSOFRRate
0.0000
CY2022Q1 oaks Weighted Average Libor Floor Rate
WeightedAverageLIBORFloorRate
0.0027 USD
CY2021Q4 oaks Weighted Average Libor Floor Rate
WeightedAverageLIBORFloorRate
0.0049 USD
CY2022Q1 oaks Weighted Average Floating Rate
WeightedAverageFloatingRate
0.939
CY2022Q1 oaks Weighted Average Sofr Rate
WeightedAverageSOFRRate
0.061
CY2021 oaks Financing Receivable Floating Rate Percentage
FinancingReceivableFloatingRatePercentage
1
CY2022Q1 oaks Average Risk Rate
AverageRiskRate
2.1
CY2021Q4 oaks Average Risk Rate
AverageRiskRate
2.3
CY2021Q2 oaks Number Of Newly Formed Subsidiaries
NumberOfNewlyFormedSubsidiaries
2 subsidiary
CY2021Q2 oaks Variable Interest Entity Qualitative And Quantitative Information Equity Interest
VariableInterestEntityQualitativeAndQuantitativeInformationEquityInterest
96250000 USD
CY2021Q2 oaks Proceeds From Issuance Of Debt Securities Allocated To Acquire Additional Loan Obligations
ProceedsFromIssuanceOfDebtSecuritiesAllocatedToAcquireAdditionalLoanObligations
330300000 USD
CY2021Q2 oaks Period To Acquire Additional Loan Obligations From Closing Date
PeriodToAcquireAdditionalLoanObligationsFromClosingDate
P180D
CY2021Q2 oaks Collateralized Loan Obligation Leverage Ratio
CollateralizedLoanObligationLeverageRatio
0.83
CY2019Q1 oaks Collateralized Loan Obligation Unamortized Discount
CollateralizedLoanObligationUnamortizedDiscount
39200000 USD
CY2022Q1 oaks Collateralized Loan Obligation Deferred Financing Costs
CollateralizedLoanObligationDeferredFinancingCosts
966700 USD
CY2021Q4 oaks Collateralized Loan Obligation Deferred Financing Costs
CollateralizedLoanObligationDeferredFinancingCosts
904498 USD
CY2022Q1 us-gaap Secured Debt
SecuredDebt
47750000 USD
CY2022Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
47750000 USD
CY2021Q4 us-gaap Secured Debt
SecuredDebt
47750000 USD
CY2021Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
47750000 USD
CY2022Q1 us-gaap Secured Debt
SecuredDebt
47750000 USD
CY2022Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
47750000 USD
CY2021Q4 us-gaap Secured Debt
SecuredDebt
47750000 USD
CY2021Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
47750000 USD
CY2022Q1 oaks Number Of Sub Servers
NumberOfSubServers
2 sub-servicer
CY2022Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
699379 USD
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
551997 USD
CY2022Q1 oaks Management Fee Percentage
ManagementFeePercentage
0.015
CY2022Q1 oaks Quarterly Management Fee Percentage
QuarterlyManagementFeePercentage
0.00375
CY2022Q1 us-gaap Management Fee Expense
ManagementFeeExpense
924617 USD
CY2021Q1 us-gaap Management Fee Expense
ManagementFeeExpense
588767 USD
CY2022Q1 us-gaap Management Fee Payable
ManagementFeePayable
929000 USD
CY2021Q1 us-gaap Management Fee Payable
ManagementFeePayable
588000 USD
CY2022Q1 oaks Incentive Fees
IncentiveFees
0 USD
CY2021Q1 oaks Incentive Fees
IncentiveFees
132232 USD
CY2022Q1 oaks Incentive Fees Payable
IncentiveFeesPayable
0 USD
CY2021Q1 oaks Incentive Fees Payable
IncentiveFeesPayable
132232 USD
CY2022Q1 oaks Reimbursable Operating Expense
ReimbursableOperatingExpense
390710 USD
CY2021Q1 oaks Reimbursable Operating Expense
ReimbursableOperatingExpense
312454 USD
CY2022Q1 oaks Reimbursable Costs Payable
ReimbursableCostsPayable
395000 USD
CY2021Q1 oaks Reimbursable Costs Payable
ReimbursableCostsPayable
311879 USD
CY2022Q1 oaks Reduction To Reimbursable Expenses As Percentage Of Exit Fees Waived Percent
ReductionToReimbursableExpensesAsPercentageOfExitFeesWaivedPercent
0.50
CY2022Q1 oaks Reimbursable Operating Expense Waived
ReimbursableOperatingExpenseWaived
603317 USD
CY2022Q1 oaks Reimbursable Operating Expense Reduction
ReimbursableOperatingExpenseReduction
301659 USD
CY2021Q1 oaks Reimbursable Operating Expense Waived
ReimbursableOperatingExpenseWaived
258240 USD
CY2021Q1 oaks Reimbursable Operating Expense Reduction
ReimbursableOperatingExpenseReduction
129120 USD
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
52225152 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52225152 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24947883 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24947883 shares
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
2954799 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
2808643 USD
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
3133509 USD
CY2021Q1 us-gaap Dividends Common Stock
DividendsCommonStock
2244904 USD
CY2022Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1184958 USD
CY2021Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
3708 USD
CY2022Q1 us-gaap Dividends
Dividends
4318467 USD
CY2021Q1 us-gaap Dividends
Dividends
2248612 USD
CY2022Q1 us-gaap Undistributed Earnings
UndistributedEarnings
-1363668 USD
CY2021Q1 us-gaap Undistributed Earnings
UndistributedEarnings
560031 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36460452 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24938883 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4500 shares
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4500 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36464952 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24943383 shares

Files In Submission

Name View Source Status
0001628280-22-013368-index-headers.html Edgar Link pending
0001628280-22-013368-index.html Edgar Link pending
0001628280-22-013368.txt Edgar Link pending
0001628280-22-013368-xbrl.zip Edgar Link pending
a20220331exhibit31-1.htm Edgar Link pending
a20220331exhibit31-2.htm Edgar Link pending
a20220331exhibit32-1.htm Edgar Link pending
a20220331exhibit32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
oaks-20220331.htm Edgar Link pending
oaks-20220331.xsd Edgar Link pending
oaks-20220331_cal.xml Edgar Link unprocessable
oaks-20220331_def.xml Edgar Link unprocessable
oaks-20220331_g1.jpg Edgar Link pending
oaks-20220331_htm.xml Edgar Link completed
oaks-20220331_lab.xml Edgar Link unprocessable
oaks-20220331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending